Author

Magda Verga

Observed names: M Verga, M. Verga

Observed institutions: University of Milan, Azienda Ospedaliera San Gerardo, Alessandro Manzoni Hospital, Azienda Ospedaliera di Desio e Vimercate, University of Milano-Bicocca

ORCID: 0009-0002-3296-6320

Observed ORCID: 0009-0002-3296-6320

OpenAlex ID: A5086177448

Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients.

2003 · Carlo Gambacorti-Passerini, Massimo Zucchetti, et al. · PubMed · 228

D-dimer before chemotherapy might predict venous thromboembolism

2009 · Guido Arpaia, Monica Carpenedo, et al. · Blood Coagulation & Fibrinolysis · 70

Incidence and outcome of pneumonia in patients with acute leukemia receiving first induction therapy with anthracycline-containing regimens.

2000 · F Rossini, M Verga, et al. · PubMed · 58

Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program

2005 · F. Rossini, E. Terruzzi, et al. · Transplant Infectious Disease · 41

Differences between in Vivo and in Vitro Sensitivity to Imatinib of Bcr/Abl+ Cells Obtained from Leukemic Patients

2002 · Carlo B. Gambacorti-Passerini, Francesca Rossi, et al. · Blood Cells Molecules and Diseases · 29

Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of disease

2001 · Carlo Gambacorti‐Passerini, Rossella Barni, et al. · British Journal of Haematology · 23

STI571 administered to chronic myeloid leukemia (CML) patients inhibits cell proliferation, induces apoptosis and initially causes partial inhibition of BCR/ABL autophosphorylation

2000 · Carlo Gambacorti‐Passerini, Magda Verga, et al. · 2

The Effects of a Modified Mediterranean Diet on Gut Microbiota and Chemotherapy Side Effects in Patients With Metastatic Colorectal Cancer Undergoing First-Line Chemotherapy With or Without Either Antiepidermal Growth Factor Receptor or Antivascular Endothelial Growth Factor Agent: Protocol for a Randomized Pilot Study in Italy

2025 · Salvatore Artale, Francesca Filiali, et al. · JMIR Research Protocols

Effect of antithrombotic prophylaxis (AP) on thrombosis-related complications and mortality in cancer patiets (pts) carrying a central venous devices (CVD)

2006 · C. Cimminiello, L. Isa, et al. · Journal of Clinical Oncology

Works count: 9

Citation count: 451

H-index: 6

I10-index: 6